Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01965665 · ClinicalTrials.gov registry record · NA

Advancing the Standard of Care for Pin Site Care

A NA study of Diabetes Mellitus and Open Reduction External Fixation, sponsored by Duke University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT01965665: Completed NA study of Diabetes Mellitus and Open Reduction External Fixation, sponsored by Duke University.

NCT01965665 is a NA study of Diabetes Mellitus and Open Reduction External Fixation that has completed, run by Duke University. The registered enrollment target is 20 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01965665, a NA study of Diabetes Mellitus and Open Reduction External Fixation, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to prospectively evaluate the effect of Active Leptospermum honey utilizing the MediHoney HCS dressing, on the occurrence of PIN site infections, and also to see if the use of MediHoney HCS reduces the frequency of dressing changes compared to published reports of routine standard pin site care.

Primary Outcome

total number of pin sites for all patients enrolled

Interventions

  • DEVICE MediHoney HCS dressing

Study Locations (1)

North Carolina

  • Duke University Medical Center/Duke South Clinics/3J - Durham

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-10
Est. Completion 2015-06
Phase NA
Duke University

1,725 total trials

What the finished NCT01965665 record still lists

NCT01965665 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which MediHoney HCS dressing is the first listed.

NCT01965665 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01965665 about?

NCT01965665 is a clinical study titled "Advancing the Standard of Care for Pin Site Care". The purpose of this study is to prospectively evaluate the effect of Active Leptospermum honey utilizing the MediHoney HCS dressing, on the occurrence of PIN site infections, and also to see if the use of MediHoney HCS reduces the frequency of dressing changes compared to published reports of routin...

What is the current status of trial NCT01965665?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-10. Estimated completion is 2015-06.

What conditions does trial NCT01965665 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Open Reduction External Fixation.

What interventions are being tested in trial NCT01965665?

The interventions under investigation include: MediHoney HCS dressing (DEVICE).

Who is sponsoring clinical trial NCT01965665?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01965665 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01965665's enrollment target sits among peer trials

20 195th of 208 higher than 11 of 208 other Diabetes Mellitus trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01965665, the US trial registry maintained by the National Library of Medicine. NCT01965665 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.